Order Article Reprints

Bommireddy R, Munoz LE, Kumari A, Huang L, Fan Y, Monterroza L, Pack CD, Ramachandiran S, Reddy SJC, Kim J, et al. Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines. 2020; 8(2):182. https://doi.org/10.3390/vaccines8020182

Bommireddy, Ramireddy, Luis E. Munoz, Anita Kumari, Lei Huang, Yijian Fan, Lenore Monterroza, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Janet Kim, and et al. 2020. "Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer" Vaccines 8, no. 2: 182. https://doi.org/10.3390/vaccines8020182

Bommireddy, R., Munoz, L. E., Kumari, A., Huang, L., Fan, Y., Monterroza, L., Pack, C. D., Ramachandiran, S., Reddy, S. J. C., Kim, J., Chen, Z. G., Saba, N. F., Shin, D. M., & Selvaraj, P. (2020). Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines, 8(2), 182. https://doi.org/10.3390/vaccines8020182